spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  neointimal hyperplasia 

 HSMN NewsFeed - 3 Jul 2017
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
Devices Interventional
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Nov 2016
OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 16 May 2014
Proteon Therapeutics Announces $45 Million of Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Mar 2012
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Feb 2012
Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 24 Sep 2010
Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Dec 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Sep 2009
Spectranetics Submits 510(k) Application to Food and Drug Administration Seeking Clearance for the Treatment of In-Stent Restenosis in the Legs
Devices Interventional
 HSMN NewsFeed - 20 May 2009
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 5 May 2009
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
Devices Interventional
 HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2008
Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2008
Elixir Medical Announces Positive Nine-Month Results From the Excella Novolimus-Eluting Coronary Stent System First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Endeavor(R) Stent Safety Profile Affirmed in Long-Term Experience
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Apr 2007
Two-year data for Angiotech's Vascular Wrap(TM) Paclitaxel-Eluting Mesh to be presented at European vascular symposium
Devices
 HSMN NewsFeed - 28 Feb 2007
Vascular BioSciences Extends Patent Portfolio
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2006
Anesiva and Lumen Therapeutics Enter Agreement Granting Lumen Access to Data From Studies in Bypass Procedures
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 9 Nov 2006
Angiotech's Vascular Wrap(TM) trial results demonstrate reduced incidence of amputation
Devices
 HSMN NewsFeed - 7 Sep 2006
SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 16 May 2006
Study Suggests Drug-Eluting Stent Type and Vessel Size are Important Predictors of Reblockage in Coronary Artery
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2006
X-Cell Medical Initiates Enrollment for ETHOS II Clinical Trial of Estradiol Eluting Stent
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
neointimal hyperplasia
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.